<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20111025007903N13</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-05-11</date_registration>
      <primary_sponsor>Tehran University of Medical Sciences</primary_sponsor>
      <public_title>Effect of Ozone injection on knee osteoarthritis</public_title>
      <acronym></acronym>
      <scientific_title>Effect of intra-articular Ozone injection on pain and function in patients with mild to moderate knee osteoarthritis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-01-15</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/63087</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Supportive, Randomization description: Patients were entered into the study using randomized block tables. We prepared 10 blocks, and six patients were considered for each block. Patient one entered block 1, patient two/block 2, patient 3/block 3… patient 10/ block 10. Then the rotation repeated again, patient 11/block 1…until patient 60/block 10, respectively. After that, the third person who he did not aware of the patients’ groups, selected 5 blocks as the control group and 5 blocks as the injection group, according to a random sequence. This method not only caused randomization to be equal in both groups but also at each stage of the study, patients were equally assigned to the groups. These small blocks kept the balance between the two groups and made the number of people in each group the same, Blinding description: Patients were blinded with a shield on the knee
The investigator and the outcome assessor were blinded about the type of injection.</study_design>
      <phase>3</phase>
      <hc_freetext>Osteoarthritis.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: For knee injection, a 22-gauge syringe was used by the classic anterolateral approach in a supine position and at an angle of 90 degrees to the knee. In the intervention group, 10 ml of 20 μg of ozone solution was used intra-articular. A total of six intra-articular injections of ozone were given to each patient for six consecutive weeks (one injection per week). After the injection, an ice pack was used at the injection site to prevent hematoma. The patients were advised to rest for up to 48 hours and continue the exercise programs afterwards. Participants were received stretching and strengthening exercise during the trial.Exercise program in the form of isometric multi-joint exercises of the muscles around the knee was defined, including the quadriceps, abductors and adductors of the thigh, holding for 10 seconds, ten repetitions three times a day. In addition, stretching exercises include stretching the hamstrings, gastrocnemius and soleus muscles, holding for 20 seconds in a state of painless stretching with a feeling of discomfort caused by stretching, which was done 1 set of 5 repetitions a day. After one month, concentric exercises of the thigh muscles (quadriceps, then abductors and adductors) with one set of 10 repetitions were started, then the number of repeats was increased to 12 repetitions. In the next step, the number of sets was increased to 3 sets per day, and finally, the weight was added by controlling patients' pain and symptoms. The mentioned program was monitored and re-educated by a sports medicine specialist in each injection session. Intervention 2: Control group: In the control group, an insulin syringe was used at the injection point without any injection, only for the feeling of the needle by patients. In addition, the patients were blinded during the injection. A total of six needling with an insulin syringe were given to each patient for six consecutive weeks (one injection per week). The exercise program was similar to the intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Zahra Alizade</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Sports Medicine Research Center, No7, Opposite of Shariati Hospital, Ale-Ahmad Highway</address>
        <city>Teanhr</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1411734143</zip>
        <telephone>+98 21 6119 2282</telephone>
        <email>z_alizadeh@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Zahra Alizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No7, Ale-Ahmad Highway, Opposite of Shariati Hospital, Tehran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>14395578</zip>
        <telephone>+98 21886302278</telephone>
        <email>z_alizadeh@tums.ac.ir</email>
        <affiliation>Tehran University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Mild to moderate knee osteoarthritis
Body mass index less than 30
Pain exacerbation with walking
Age between 45 and 75 years</inclusion_criteria>
      <agemin>45 years</agemin>
      <agemax>75 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>History of knee trauma or surgery, metabolic  or autoimmune diseases
Knee effusion
Pregnancy or lactation
Usage of anti-coagulant drugs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>M17</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Osteoarthritis of knee</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Other</i_code>
      <i_code>Placebo</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: For knee injection, a 22-gauge syringe was used by the classic anterolateral approach in a supine position and at an angle of 90 degrees to the knee. In the intervention group, 10 ml of 20 μg of ozone solution was used intra-articular. A total of six intra-articular injections of ozone were given to each patient for six consecutive weeks (one injection per week). After the injection, an ice pack was used at the injection site to prevent hematoma. The patients were advised to rest for up to 48 hours and continue the exercise programs afterwards. Participants were received stretching and strengthening exercise during the trial.Exercise program in the form of isometric multi-joint exercises of the muscles around the knee was defined, including the quadriceps, abductors and adductors of the thigh, holding for 10 seconds, ten repetitions three times a day. In addition, stretching exercises include stretching the hamstrings, gastrocnemius and soleus muscles, holding for 20 seconds in a state of painless stretching with a feeling of discomfort caused by stretching, which was done 1 set of 5 repetitions a day. After one month, concentric exercises of the thigh muscles (quadriceps, then abductors and adductors) with one set of 10 repetitions were started, then the number of repeats was increased to 12 repetitions. In the next step, the number of sets was increased to 3 sets per day, and finally, the weight was added by controlling patients' pain and symptoms. The mentioned program was monitored and re-educated by a sports medicine specialist in each injection session.</i_keyword>
      <i_keyword>Control group: In the control group, an insulin syringe was used at the injection point without any injection, only for the feeling of the needle by patients. In addition, the patients were blinded during the injection. A total of six needling with an insulin syringe were given to each patient for six consecutive weeks (one injection per week). The exercise program was similar to the intervention group.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Knee pain. Timepoint: before intervention, 6 weeks and, 6 months after injection. Method of measurement: Visual Analogue Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Function. Timepoint: before intervention, 6 weeks and, 6 months after injection. Method of measurement: 6minute walking test.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tehran University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2019-12-28</approval_date>
        <contact_name>Research Ethics Committees of Imam Khomeini Hospital Complex- Tehran University of Medical Sciences</contact_name>
        <contact_address>Dr. Gharib street, Tohid square TEHRAN Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
